Epithalon

Epithalon is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG) and a molecular weight of 390.35 g/mol. Developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology as a synthetic analogue of Epithalamin. The primary biological context driving research interest is its reported interaction with telomere homeostasis — specifically its putative capacity to stimulate telomerase (hTERT) expression and activity in somatic cell models.

The primary research applications center on cellular aging biology, telomere homeostasis research, and senescence pathway investigation. In vitro applications include hTERT gene expression assays, telomere length quantification assays, and senescence-associated beta-galactosidase staining studies. Comparative pharmacology studies contrasting Epithalon with other longevity-associated research peptides — such as SS-31 or MOTS-C — benefit from Epithalon's well-documented preclinical publication record.

Every batch undergoes independent third-party HPLC analysis prior to release. As a tetrapeptide, Epithalon is subject to specific synthesis quality considerations. Our ≥99% purity guarantee reflects the resolution of the complete chromatographic profile. All purity testing is conducted by certified third-party laboratories entirely independent of our production process.

This product is strictly for research and laboratory use only. It is not approved by the FDA or any global regulatory body for human consumption, veterinary use, or therapeutic application. The purchaser assumes all responsibility for the proper handling, storage, and application of this compound. It must only be handled by qualified professionals in a controlled laboratory setting. By purchasing this product, you agree to abide by all local and international laws regarding the use of research chemicals.